European Heart Journal Advance Access published online on May 23, 2006
European Heart Journal, doi:10.1093/eurheartj/ehl040
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
* To whom correspondence should be addressed. Aims Women with chest pain but without obstructive coronary artery disease (CAD) are considered at low risk for cardiovascular (CV) events, but half continue to experience debilitating chest pain over many years. This study compared CV outcomes in women with persistent chest pain (PChP) vs. those without PChP. Methods and results We studied 673 Women's Ischaemia Syndrome Evaluation (WISE) participants with chest pain undergoing coronary angiography for suspected myocardial ischaemia and at least 1 year of follow-up. PChP was defined as self-reported continuing chest pain after 1 year. Events occurring after that year were recorded for a median of 5.2 years. We compared CV event rates for women with and without PChP in subgroups with and without obstructive CAD. The median age was 58 years, 20% were racial minorities, 45% had PChP, 39% had obstructive CAD. Among women without CAD, those with PChP had more than twice the rate of composite CV events (P=0.03), that included non-fatal myocardial infarctions (P=0.11), strokes (P=0.03), congestive heart failure (P=0.38), and CV deaths (P=0.73), compared with those without PChP. In women with CAD, there was no difference in composite CV events in those with and without PChP (P=0.72). Conclusion Among women undergoing coronary angiography for suspected myocardial ischaemia, PChP in women with no obstructive CAD predicted adverse CV outcomes. Such women might benefit from additional evaluation and aggressive risk factor modification therapy.
Received October 21, 2005
Revised April 14, 2006
Accepted May 4, 2006
Clinical research
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study
B. Delia Johnson 1 *,
Leslee J. Shaw 2,
Carl J. Pepine 3,
Steven E. Reis 4,
Sheryl F. Kelsey 1,
George Sopko 5,
William J. Rogers 6,
Sunil Mankad 7,
Barry L. Sharaf 8,
Vera Bittner 6,
and
C. Noel Bairey Merz 2
2 Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
3 Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
4 Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
5 National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA
6 Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
7 Division of Cardiology, Department of Medicine, Allegheny University of the Health Sciences, Pittsburgh, PA, USA
8 Division of Cardiology, Rhode Island Hospital, RI, USA
B. Delia Johnson, E-mail: djohnson{at}edc.pitt.edu.
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. J. Shaw, R. Bugiardini, and C. N. B. Merz Women and ischemic heart disease: evolving knowledge. J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1561 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Blankstein, L. D. Shturman, I. S. Rogers, J. A. Rocha-Filho, D. R. Okada, A. Sarwar, A. V. Soni, H. Bezerra, B. B. Ghoshhajra, M. Petranovic, et al. Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J. Am. Coll. Cardiol., September 15, 2009; 54(12): 1072 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings Cardiovasc Res, November 1, 2008; 80(2): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bittner Angina Pectoris: Reversal of the Gender Gap Circulation, March 25, 2008; 117(12): 1505 - 1507. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sangle and D. D'Cruz Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome Lupus, February 1, 2008; 17(2): 83 - 85. [PDF]
|
|
|
|
 |
|
 A. D Timmis, G. Feder, and H. Hemingway Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution Heart, July 1, 2007; 93(7): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M Gruen and C. J Pepine Raising awareness of angina in women Heart, March 1, 2007; 93(3): 279 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Other articles noted Evid. Based Med., October 1, 2006; 11(5): 159 - 160. [Full Text] [PDF]
|
|
|
|
 |
|
 Persistent chest pain predicts cardiovascular disease in women with a normal angiogram BMJ, July 15, 2006; 333(7559): . [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bugiardini Women, 'non-specific' chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcome Eur. Heart J., June 2, 2006; 27(12): 1387 - 1389. [Full Text] [PDF]
|
|